These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 8711364)

  • 1. [The effect of lovastatin on the development of adriamycin nephropathy in rats].
    Tesar V; Zima T; Poledne R; Stejskalová A; Tĕmínová J; Stípek S
    Sb Lek; 1995; 96(1):35-42. PubMed ID: 8711364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The effect of pefloxacin on nephrotic syndrome in experimental adriamycin nephropathy].
    Zima T; Tesar V; Rychlík I; Nĕmecek K; Poledne R; Stejskalová A; Tĕmínová J; Stípek S; Merta M
    Cas Lek Cesk; 1995 Oct; 134(20):658-60. PubMed ID: 7489582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The effect of chronic administration of ethanol on experimental adriamycin nephropathy].
    Tesar V; Zima T; Poledne R; Stejskalová A; Stípek S; Tĕmínová J
    Cas Lek Cesk; 1994 May; 133(9):268-71. PubMed ID: 8194094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of chronic ethanol administration on adriamycin-induced nephrotic syndrome in rats.
    Tesar V; Zima T; Poledne R; Stejskalová A; Stípek S; Tĕmínová J
    Alcohol Alcohol; 1995 Jan; 30(1):47-53. PubMed ID: 7748275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of losartan and enalapril on urinary excretion of 8-isoprostane in experimental nephrotic syndrome].
    Tesar V; Zima T; Jirsa M; Crkovská J; Stípek S; Vernerová Z; Seráková M
    Cas Lek Cesk; 1999 Oct; 138(18):560-4. PubMed ID: 10596472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Lipid metabolism in the nephrotic syndrome].
    Tesar V; Merta M; Poledne R; Tĕmínová J; Zima T; Rychlík I; Zabka J; Stejskalová A
    Sb Lek; 1996; 97(1):143-50. PubMed ID: 8711410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipid lowering: an important factor in preventing adriamycin-induced heart failure.
    Iliskovic N; Singal PK
    Am J Pathol; 1997 Feb; 150(2):727-34. PubMed ID: 9033285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction in proteinuria attenuates hyperlipidemia in the nephrotic syndrome.
    Kaysen GA; Davies RW
    J Am Soc Nephrol; 1990 Nov; 1(5 Suppl 2):S75-9. PubMed ID: 16989070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term effect of lovastatin on lipoprotein profile in patients with primary nephrotic syndrome.
    Prata MM; Nogueira AC; Pinto JR; Correia AM; Vicente O; Rodrigues MC; Miguel MJ
    Clin Nephrol; 1994 May; 41(5):277-83. PubMed ID: 8050207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of deferoxamine, N-acetylcysteine and selenium treatments in rats with Adriamycin-induced nephrotic syndrome.
    Bulucu F; Oktenli C; Kenar L; Ocal R; Koc B; Inal V; Yamanel L; Yaman H; Sanisoglu YS; Aydin A
    J Nephrol; 2008; 21(4):576-83. PubMed ID: 18651549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-activity relationship for two lipoxygenase inhibitors and their potential for inducing nephrotic syndrome.
    Morley TJ; Evans GO; Goodwin DA; Read NG; Hodgson ST; Hawksworth GM
    Toxicol Appl Pharmacol; 1997 Oct; 146(2):299-308. PubMed ID: 9344898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Long-term administration of cyclosporine A in patients with IgA nephropathy].
    Chábová V; Tesar V; Zabka J; Rychlík I; Merta M; Jirsa M; Stejskalová A; Stejskal J
    Cas Lek Cesk; 1996 Dec; 135(24):803-6. PubMed ID: 9072300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prospective clinical trial comparing the treatment of idiopathic membranous nephropathy and nephrotic syndrome with simvastatin and diet, versus diet alone.
    Rayner BL; Byrne MJ; van Zyl Smit R
    Clin Nephrol; 1996 Oct; 46(4):219-24. PubMed ID: 8905205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of losartan and enalapril on urinary excretion of 8-isoprostane in experimental nephrotic syndrome.
    Tesar V; Zima T; Jirsa M; Crkovská J; Stípek S; Vernerová Z; Seráková M
    Med Sci Monit; 2002 Feb; 8(2):BR69-74. PubMed ID: 11859270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of anti-hyperlipidaemic agent or dietary protein restriction on progressive renal deterioration in adriamycin-induced nephropathy in rats.
    Washio M; Nanishi F; Onoyama K; Okuda S; Fujishima M
    Int Urol Nephrol; 1993; 25(3):295-303. PubMed ID: 8225831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of delayed treatment with enalapril and/or lovastatin on the progression of glomerulosclerosis in 5/6 nephrectomized rats.
    Lee SK; Jin SY; Han DC; Hwang SD; Lee HB
    Nephrol Dial Transplant; 1993; 8(12):1338-43. PubMed ID: 8159302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lovastatin ameliorates depressed intraglomerular proteolytic activities in experimental nephrotic syndrome.
    Teschner M; Paczek L; Schaefer L; Bahner U; Heidland A; Schaefer RM
    Res Exp Med (Berl); 1994; 194(6):349-56. PubMed ID: 7716342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enalapril prevents fatty liver in nephrotic rats.
    Toblli JE; Ferder L; Stella I; Angerosa M; Inserra F
    J Nephrol; 2002; 15(4):358-67. PubMed ID: 12243364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rationale and management of hyperlipidemia of the nephrotic syndrome.
    Grundy SM; Vega GL
    Am J Med; 1989 Nov; 87(5N):3N-11N. PubMed ID: 2486542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exposure to hydrocarbons and renal disease: an experimental animal model.
    Mutti A; Coccini T; Alinovi R; Toubeau G; Broeckaert F; Bergamaschi E; Mozzoni P; Nonclercq D; Bernard A; Manzo L
    Ren Fail; 1999; 21(3-4):369-85. PubMed ID: 10416216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.